Specialties › Neurology Billing
Neurology is one of the most CPT-code-dense specialties in all of medicine. A single patient encounter can span an office E&M, an in-office EEG interpretation, an infusion administration, a drug J-code, a prior authorization, and a neuromonitoring fee — each a separate billable event with its own documentation standard. Generalist billing teams miss 25–40% of neurology revenue. ParaMed's neurology billing specialists capture every code, every infusion hour, and every drug unit — systematically, on every encounter.
The average neurology practice forfeits $290,000–$840,000 annually to missed infusion add-on hours, under-coded monitoring studies, wrong drug J-codes, and unbilled concurrent care. A ParaMed neurology billing audit identifies every revenue gap in 30 days — at no cost.
Established · 3.5 hr infusion · E&M combined · In-office infusion suite · BCBS PPO
Infusion management E&M · Separate documented office visit component
First hour of therapeutic infusion · Primary administration code
Hours 2–3 · Add-on code × 2 additional hours billed
Per-unit J-code · 300mg dose · ASP + 6% CMS rate
Revenue Alert Resolved: Prior billing team missing 96415 add-on hours — billed only 96413 for all infusions. For 3.5-hr infusions, this omission costs $192 per encounter × 48 annual Ocrevus infusions = $9,216/year from one patient alone.
Neurology uniquely combines high-cost drug infusion billing, time-based monitoring study billing, complex E&M with neurological examination requirements, hospital and concurrent care billing, and specialty-specific prior authorization burdens — all in a single practice. No other outpatient specialty requires billing expertise across as many distinct revenue categories simultaneously.
The neurology in-office infusion suite is a major revenue center — but only when infusion administration codes (96413, 96415, 96417), drug J-codes, waste billing, and concurrent E&M modifiers are all applied correctly on every encounter. Most practices collect 60–75% of what they should from infusion encounters due to missed add-on hours and incorrect drug billing.
Neurophysiology studies generate two separate billable components: the technical component (the study itself) and the professional component (the physician's interpretation and report). Each component is billed separately — and many neurologists miss either the technical or professional billing entirely.
Neurology drug billing for MS biologics, anti-CGRP migraine drugs, complement inhibitors, and other high-cost specialty pharmaceuticals requires per-unit J-code accuracy, correct dosing unit calculation, waste billing with modifier JW for unused drug from opened vials, and prior authorization maintenance.
Hospital-based neurology generates inpatient consultation codes (99252–99255), subsequent hospital care codes (99231–99233), and concurrent care billing when multiple specialists manage different conditions. Neurology consults are among the most commonly under-billed hospital services.
General neurology, MS, epilepsy, movement disorders, headache, and neuromuscular disease each have distinct CPT code families, prior authorization requirements, and documentation standards. Select your subspecialty to see the complete billing picture.
General neurology billing covers the outpatient E&M visits, inpatient consultations, and hospital follow-up visits that form the core revenue stream of any neurology practice. The key billing decisions — complexity level, consultation vs. follow-up, concurrent care eligibility — are made on every encounter and significantly affect revenue capture.
| CPT | Description | Avg. Rate |
|---|---|---|
| 99214 | E&M Established — Moderate MDMT2 | $148 |
| 99215 | E&M Established — High MDMT1 | $218 |
| 99205 | New Patient — High ComplexityT1 | $328 |
| 99254 | Inpatient Consult — ModerateT2 | $248 |
| 99255 | Inpatient Consult — HighT1 | $348 |
| 99232 | Subsequent Hospital CareDaily | $112 |
| 99483 | Cognitive Impairment AssessmentAnnual | $282 |
| 99490 | Chronic Care Management (20 min)Monthly | $62 |
MS is the highest-revenue subspecialty in outpatient neurology — because MS patients require frequent high-cost biologic infusions, regular neurological monitoring visits, and MRI surveillance. The infusion suite billing for MS treatments (Ocrevus, Tysabri, Lemtrada) generates $8,000–$40,000+ per infusion encounter.
| Code | Drug / Service | Avg. Rate |
|---|---|---|
| J0791 | Ocrevus — 1mg unit (300mg)High | $24,180 |
| J2323 | Tysabri Natalizumab — 1mgHigh | $6,840 |
| J0202 | Alemtuzumab (Lemtrada) — 1mgHigh | $18,200 |
| 96413 | Initial Infusion HourAdmin | $168 |
| 96415 | Additional Infusion Hour (each)Add-On | $96 |
| 99214 | Same-Day E&M with Mod -25Sep | $148 |
| 70553 | MRI Brain w/ ContrastSurveillance | $420 |
Epilepsy billing centers on neurophysiology studies (routine and prolonged EEG), ambulatory and long-term video EEG monitoring (LTM), VNS device management, and anti-seizure medication monitoring requiring frequent visits.
| Code | Study | Avg. Rate |
|---|---|---|
| 95812 | EEG 20–40 min with interpretationT3 | $286 |
| 95813 | EEG >40 min — ProlongedT2 | $468 |
| 95715 | 24-hr Ambulatory EEG — TechnicalTC | $382 |
| 95717 | LTM EEG >= 2hrs — No VideoT1 | $640 |
| 95720 | LTM Video EEG >= 2hrs per dayT1 | $892 |
| 95972 | VNS Programming SimpleT3 | $186 |
| 95976 | VNS Programming ComplexT2 | $240 |
Movement disorder billing combines DBS device management (programming, interrogation), botulinum toxin injection billing (J-code drug + injection administration + guidance), and specialized Parkinson's monitoring visits. DBS programming visits (95983/95984) generate significantly more revenue than standard E&M visits.
| Code | Service | Avg. Rate |
|---|---|---|
| 95983 | DBS Programming — First 15 minT1 | $248 |
| 95984 | DBS Programming — Add'l 15 minAdd-On | $136 |
| J0585 | Botulinum A (Botox) per unitDrug | $9.62/u |
| 64615 | Chemodenervation — CervicalProc | $428 |
| 64644 | Chemodenervation — 1 ExtremityProc | $342 |
| 76882 | US Guidance for InjectionAdd-On | $148 |
| 95873 | EMG Guidance for InjectionAdd-On | $168 |
Headache subspecialty billing has been transformed by anti-CGRP monoclonal antibodies — Aimovig, Ajovy, Emgality, and Vyepti — each with their own HCPCS/J-codes, administration routes, and prior authorization requirements. Additionally, occipital nerve blocks, trigger point injections, and Botox for chronic migraine are high-value procedures with specific documentation requirements.
| Code | Service | Avg. Rate |
|---|---|---|
| 64405 | Greater Occipital Nerve BlockProc | $124 |
| 20552 | Trigger Point Injection — 1–2 SitesProc | $68 |
| J3031 | Aimovig (Erenumab) 70mgDrug | $640 |
| J3032 | Ajovy (Fremanezumab) 225mgDrug | $680 |
| J3033 | Emgality (Galcanezumab) 120mgDrug | $620 |
| J0585 | Botox for Chronic Migraine (per unit)Drug | $9.62/u |
| 64615 | Chemodenervation — Head/NeckProc | $428 |
Neuromuscular disease billing is anchored by electromyography (EMG) and nerve conduction study (NCS) billing — among the most complex and most scrutinized billing areas in all of neurology due to their volume and the granularity of correct code selection. Additionally, SMA gene therapy and ALS disease-modifying therapy represent some of the most revenue-intensive encounters in all of medicine.
| Code | Study | Avg. Rate |
|---|---|---|
| 95861 | EMG — 2 ExtremitiesT2 | $248 |
| 95864 | EMG — 4 ExtremitiesT1 | $412 |
| 95907 | NCS — 1–2 StudiesT3 | $280 |
| 95909 | NCS — 3–4 StudiesT3 | $380 |
| 95911 | NCS — 7–8 StudiesT2 | $820 |
| 95913 | NCS — 13+ StudiesT1 | $1,240 |
| J3590 | Unclassified Biologic (Zolgensma)Gene Rx | ~$2.1M |
For each major neurology diagnosis, there is a set of CPT codes, HCPCS drug codes, and monitoring codes that should be billed together — but most practices capture only a fraction. This mapper shows what a complete code set looks like for the most common neurology diagnoses.
G35 · Infusion visit · Established patient
G40.009 · EEG with interpretation
G24.3 · Botox injection visit
Epilepsy billing centers on EEG studies (routine + prolonged), ambulatory monitoring, LTM video EEG for presurgical evaluation, and anti-seizure medication monitoring visits. Complete billing requires separate technical and professional components for each study performed.
MS generates the highest per-encounter revenue in outpatient neurology through biologic infusion billing. Complete billing: E&M -25, initial + all add-on infusion hours, drug J-code per unit, waste billing JW modifier, and annual PA management.
Parkinson's billing includes DBS device programming (95983/95984 — higher value than generic E&M), botulinum toxin for related dystonia, and motor function assessment to support MDM level selection.
Chronic migraine billing includes CGRP monoclonal antibody billing (J3031–J3033), Botox for chronic migraine (J0585 by unit + 64615), occipital nerve blocks (64405), and trigger point injections — each separately billable from the E&M visit with modifier -25.
Neuromuscular disease generates high-value EMG and NCS studies — with NCS code selection driven by the number of nerve studies documented. ALS and SMA drug therapy requires J-code billing at exceptionally high per-dose values with specific authorization protocols.
Post-stroke neurology follow-up billing includes E&M visits with high-MDM code selection, carotid duplex studies (93880), cognitive screening, and coordination with rehabilitation billing. Concurrent care coding applies when stroke is managed alongside cardiology or PM&R.
An in-office neurology infusion for Ocrevus or Tysabri generates $8,000–$40,000+ per encounter in drug billing alone — but only when the administration codes, add-on hours, and E&M modifier are all applied correctly.
Office visit for infusion management — must be documented separately from infusion administration. Requires distinct clinical documentation beyond infusion administration alone.
99214$148Mod -25 RequiredFirst hour of therapeutic infusion — primary administration code. Only one primary infusion code per encounter regardless of number of drugs.
96413$168Primary Code96415 billed for EACH additional hour beyond the first. A 3-hour infusion requires 96413 + 96415 × 2. The single most commonly missed code in neurology infusion billing.
96415 × N$96/hrPer Add-On HourHCPCS J-code for the specific drug infused — billed per unit (per mg or per mL depending on drug). Completely separate from and in addition to the administration codes.
J-Code × Units$8K–$40KPer-Unit PricingWhen a partial vial is opened and unused drug is discarded, modifier JW documents the discarded amount — billing the payer for the entire opened vial including unused drug per CMS policy.
J-Code + JWVariableJW ModifierAdministered as 300mg q6mo (year 1 split doses) then 600mg q6mo. Among the highest-value outpatient infusions in all of neurology. Each 300mg dose is a 3-hour infusion requiring 96413 + 96415 × 2 in addition to the J-code.
300mg monthly infusion — 1-hour typical infusion time. Monthly recurrence makes PA renewal and scheduling management critical. JCV antibody monitoring required for PML risk assessment.
Among the most expensive drugs in neurology — Soliris eculizumab for neuromyelitis optica spectrum disorder (NMOSD). Highest-value outpatient infusion billing. Requires meningococcal vaccination documentation before PA approval.
High-dose IVIG for autoimmune neuromuscular diseases. Billing requires J1569 (Gammagard), J1568 (other IVIG), or brand-specific code per gram administered. Multi-day infusion sequences require per-day billing with all administration codes each day.
The only IV anti-CGRP monoclonal antibody for migraine prevention — administered quarterly as a 30-minute infusion. Billing combines infusion administration codes, J-code per vial, and quarterly E&M monitoring visit.
ALS disease-modifying therapy — 28-day initial cycle with daily infusions for 14 days, then 10 days per 28-day cycle. Each daily infusion session billed separately with administration codes.
Neurophysiology monitoring studies are the technical backbone of neurology — and one of the most misunderstood billing areas. Each study type has a technical component, a professional component, and in many cases separate add-on codes for extended duration or additional parameters.
Routine, prolonged, ambulatory, and long-term video EEG monitoring — each duration tier is a different, higher-value code family
Standard outpatient EEG with physician interpretation. When neurologist owns equipment: bill -TC (technical) + -26 (professional) separately or global code 95812 when both components belong to the same practice.
$286 global / $148 TC + $138 PCApplies when total recording + review time exceeds 40 minutes. Requires documentation of total EEG duration. Generates $182 more than 95812 — one of the most commonly under-utilized duration upgrades in neurology.
$468 global — +$182 vs. 9581224-hour ambulatory EEG recording — technical component for equipment application, recording, and download. Professional component (interpretation) billed separately as 95716-26.
$382 TC + $198 PCInpatient/outpatient LTM video EEG — billed per calendar day of monitoring with physician daily review. Highest-value EEG code family — epilepsy monitoring unit patients generate this daily.
$892/day (technical + professional)Needle EMG — code selection based on number of extremities examined and whether the limb girdle muscles are also tested
Needle EMG of one upper or lower extremity with physician interpretation. Code selection requires documentation identifying the specific muscles examined.
$152 avg.Two extremity EMG — commonly performed bilateral upper extremity for carpal tunnel, bilateral lower extremity for radiculopathy evaluation. Documents both extremities examined with specific muscle list for each.
$248 avg.Full 4-extremity EMG — highest-value needle EMG code. Appropriate for polyneuropathy evaluation, ALS diagnosis, generalized weakness. Requires complete muscle documentation per extremity.
$412 avg.Needle EMG of cranial nerve innervated muscle — facial nerve EMG, accessory nerve studies. Rarely coded correctly in practices performing these studies routinely.
$128 avg.Code selection based on the total number of nerve conduction studies performed — each individually documented nerve counts as one study
Lowest-tier NCS code — applies only when just 1 or 2 individual nerve studies are performed. Commonly over-billed when a full NCS panel is performed but only 95907 is billed due to non-specialist billing.
$280 avg. — most under-coded tierMid-range NCS code — applicable to a standard nerve conduction panel. A typical bilateral upper extremity NCS (median, ulnar each side motor + sensory = 8 studies) correctly maps to 95911, not 95907. The difference is $540 per study.
$820 avg. vs. $280 for 95907Highest-value NCS code — for comprehensive panels including bilateral upper and lower extremity nerve conduction studies. A full polyneuropathy NCS panel typically involves 14–18 individual studies.
$1,240 avg.Automated nerve conduction testing — billed per limb, not per study count. Different code family from standard NCS — billing 95907–95913 for automated device testing is a billing error that creates audit risk.
$186/limb avg.When a prior authorization lapses for an Ocrevus infusion, the patient misses their scheduled dose — a clinical and financial disruption that costs the practice $24,000+ in deferred revenue per missed infusion. Neurology's high-cost biologics require proactive PA management with step therapy documentation, annual renewal tracking, and peer-to-peer appeal protocols for every initial denial.
MRI confirming relapsing-remitting MS, clinical criteria (McDonald criteria), prior treatment history — all compiled into the PA submission package. Incomplete submissions are the #1 cause of initial denials.
ParaMed Compiles PackageMost payers require documented failure of at least one first-line MS therapy before approving Ocrevus. ParaMed builds the step therapy failure narrative — exact dates, dosing, adverse events, or inadequate response — into every Ocrevus PA request.
Payer-Required StepComplete PA package submitted electronically — including clinical notes, MRI reports, step therapy documentation, and prescriber attestation. ParaMed targets 10-day advance submission before infusion date to protect the schedule against processing delays.
10 Days Before InfusionWhen initial PA is denied, ParaMed schedules a peer-to-peer review between the neurologist and the payer's medical director within 48 hours — achieving 78% reversal rate when properly prepared.
Initial Denial CommonP2P RequestedApproval secured and infusion scheduled. ParaMed's PA renewal calendar tracks every active authorization with 60-day advance renewal alerts — ensuring no infusion encounter ever faces a lapsed authorization.
PA ApprovedRenewal TrackedEach neurology biologic has a distinct PA requirements checklist. Missing a single element from the submission package causes an automatic initial denial — delaying infusion and revenue by weeks.
44% of neurologists seeing hospitalized patients don't bill concurrent care codes, 31% under-document inpatient consults to 99252–99253 when the clinical complexity supports 99254–99255, and nearly all miss ongoing hospital visit billing after the initial consult.
A hospitalist requests neurology consultation for new-onset seizure. The neurologist performs a comprehensive evaluation, reviews prior imaging, orders EEG, and writes a formal consult note with recommendations — high medical decision making complexity.
A patient is admitted with ischemic stroke. Cardiology manages AFib. Neurology manages the stroke — ordering tPA, managing NIHSS monitoring, coordinating MRI/MRA. Both specialties bill their own daily hospital visits independently.
A patient is admitted to the epilepsy monitoring unit for 5-day video EEG monitoring. The neurologist reviews daily EEG recordings, adjusts medications, and writes daily notes — all billable as daily hospital visits plus daily LTM EEG professional component.
A neurologist who bills only the initial consult and skips concurrent care, daily visits, and monitoring code professional components — the pattern in 44% of hospital neurology practices.
The same 5-day admission billed correctly — every E&M code, every monitoring professional component, every concurrent care visit captured from day one through discharge.
These are not one-off billing mistakes — they are systematic, recurring patterns that compound across hundreds of encounters per year. Every one is preventable. Every one is costing your practice real money right now.
The single highest-volume revenue loss in neurology billing: billing only 96413 for every infusion encounter regardless of total duration. 96415 must be billed for EACH additional hour beyond the first. A 3-hour Ocrevus infusion missing 2 add-on hours loses $192 per encounter. In a practice administering 25 infusions monthly with an average 2.5-hour duration, this is $28,800 monthly — $345,600 annually — from one omitted code family.
Using 95907 (1–2 nerve conduction studies, $280) for a comprehensive NCS panel that actually performed 8–14 individual nerve studies (which maps to 95911 at $820, or 95913 at $1,240) is the most costly NCS billing error. For a practice performing 15 NCS studies weekly, correct tier coding vs. defaulting to 95907 represents $8,100–$14,400 per week in recoverable revenue.
Botulinum toxin J-codes (J0585 for onabotulinumtoxinA) are billed per unit administered — not per vial. Billing J0585 × 1 when 200 units were administered generates $9.62 instead of $1,924 — a $1,914 loss on a single encounter. For a headache practice administering 200 units of Botox to 20 patients monthly, correct unit billing vs. vial billing represents $38,280 monthly in difference.
When a neurologist performs a separately documentable evaluation and management service on the same day as an infusion, that E&M service is separately billable with modifier -25. Many practices don't bill the same-day E&M at all, or bill it without -25 causing automatic denial. In an MS practice with 40 monthly infusions, missing the infusion-day E&M costs $5,920 monthly ($71,040 annually).
When a neurologist interprets an EEG performed with in-practice equipment, both the technical component and the professional component (the neurologist's interpretation and written report) are separately billable with modifiers -TC and -26. The majority of neurology practices either bill only the global code or miss the professional interpretation billing entirely when the EEG was performed by a hospital or outpatient facility and the neurologist read it independently.
Deep brain stimulator programming visits are billed with DBS device programming codes (95983 for first 15 minutes + 95984 for each additional 15 minutes) — not standard E&M codes. Practices that bill 99214 for DBS programming visits lose $100–$372 per encounter compared to correct procedure coding. In a movement disorder practice programming 15 DBS patients monthly, using 95983/95984 instead of 99214 generates an additional $1,500–$5,580 monthly.
When a single-dose drug vial is opened and only a portion is administered, modifier JW documents the discarded unused portion — and the payer reimburses the entire opened vial per CMS policy. Practices that never apply JW are effectively donating the cost of partially-used drug vials to the payer. For high-cost neurology drugs, each missed JW billing represents hundreds to thousands of dollars per encounter in unreimbursed drug cost.
From in-office infusion suite management to hospital concurrent care billing to EEG professional component capture to prior authorization management — ParaMed covers the full spectrum of neurology billing complexity.
Complete infusion encounter billing — initial + all add-on hours, drug J-codes per documented unit, waste billing with JW modifier, same-day E&M with -25, and prior authorization management for every drug in every infusion schedule.
EEG, EMG, and NCS billing with correct component coding — technical vs. professional component routing, NCS tier code selection based on documented study count, and prolonged monitoring code application for extended duration studies.
End-to-end PA management for all high-cost neurology drugs — submission, tracking, peer-to-peer appeal coordination, annual renewal management, and step therapy documentation for every biologic on your formulary.
Complete inpatient neurology billing — initial and follow-up consults at correct complexity levels, concurrent care daily visit billing, discharge services, and EEG professional component billing for all hospital-based monitoring studies.
Per-unit J-code billing for all neurology specialty pharmaceuticals — correct unit calculation from physician-documented doses, brand-specific J-code selection, waste billing, and coordination with specialty pharmacy for buy-and-bill drug programs.
Subspecialty-specific revenue review — DBS programming code application for movement disorders, CGRP biologic billing for headache, NCS quantity optimization for neuromuscular, and cognitive assessment code identification for dementia practices.
A 5-step workflow built specifically for neurology's complexity — infusion verification, monitoring code tier selection, drug unit billing, hospital concurrent care capture, and clean claim submission on every encounter.
Each encounter categorized: office visit, infusion, monitoring study, hospital, or combined — routing to the appropriate billing specialist workflow for that encounter type.
Infusion hours counted from nursing record. NCS studies counted from report. Drug units extracted from dose documentation. DBS programming time mapped to 95983/95984.
PA status confirmed before every infusion encounter. Drug approval, diagnosis code match, and authorizing plan verified — no infusion claim submitted without confirmed authorization.
Claims submitted within 96 hours. 97.8% first-pass acceptance. All modifiers applied. Electronic tracking through payment posting.
Monthly neurology-specific revenue dashboard: infusion revenue per drug, monitoring code capture rate, PA approval rate, and denial pattern tracking by category.
"Our previous billing team billed 96413 for every single infusion — whether it was 1 hour or 4 hours. We had no idea 96415 existed as an add-on per hour until ParaMed's audit. We were seeing 28 MS infusion patients monthly with average 3-hour infusion times, billing only $168 per infusion for administration codes instead of $360. That's $5,376 per month in missed revenue from a single code family. ParaMed recovered $38,000 from retroactive appeals and fixed it permanently going forward."
"I run a high-volume EMG lab. We were billing 95907 for every nerve conduction study regardless of how many nerves we tested. Our standard peripheral neuropathy panel tests 12 nerves — which correctly maps to 95913 at $1,240, not 95907 at $280. ParaMed audited six months of NCS claims and found we'd under-coded $186,000 in that period alone. They rebuilt our NCS billing protocol from scratch. We haven't under-coded a single NCS study since."
"As a movement disorder specialist doing 22 Botox patients monthly, I was billing J0585 × 1 for every patient — thinking it was billed per injection, not per unit. ParaMed showed me I should have been billing J0585 × 155 (our average dose). At Medicare's ASP rate that's $1,491 per patient vs. $9.62. I had been collecting less than 1% of my Botox drug revenue for two years. ParaMed rebuilt the billing and the revenue change was immediate and extraordinary."
Whether you're losing revenue on infusion add-on hours, under-coding NCS tier levels, missing E&M codes on infusion days, or leaving DBS programming revenue behind — a ParaMed neurology billing audit identifies the exact revenue gaps in your practice within 30 days. No cost, no commitment.
Every infusion encounter reviewed for add-on hour completeness, drug unit accuracy, waste billing, and same-day E&M capture. Revenue gap quantified in writing within 30 days.
All NCS reports reviewed for correct tier code selection. All EEG interpretations audited for professional component billing. Current vs. correct reimbursement calculated per study type.
All active high-cost drug authorizations reviewed for expiration risk. Step therapy documentation evaluated for renewal readiness. Denial pattern analysis for prior 6 months of PA decisions.
Tell us about your practice and we'll show you exactly where the revenue gaps are.
Trusted by Practices Across US — Feedback from providers who rely on ParaMed for smarter Medical Billing.
